Design of clinical trials to assess diabetes treatment: Minimum duration of continuous glucose monitoring data to estimate time‐in‐ranges with the desired precision
出版年份 2021 全文链接
标题
Design of clinical trials to assess diabetes treatment: Minimum duration of continuous glucose monitoring data to estimate time‐in‐ranges with the desired precision
作者
关键词
-
出版物
DIABETES OBESITY & METABOLISM
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2021-07-02
DOI
10.1111/dom.14483
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Time in range: a new parameter to evaluate blood glucose control in patients with diabetes
- (2020) Monica Andrade Lima Gabbay et al. Diabetology & Metabolic Syndrome
- 877-P: Limits of Correlation Coefficient Analysis in Determining the Minimal Duration of CGM Data Needed to Estimate Time Below Range
- (2020) NUNZIO CAMERLINGO et al. DIABETES
- Robust determination of the optimal continuous glucose monitoring length of intervention to evaluate long-term glycaemic control
- (2020) Pau Herrero et al. Diabetes Technology & Therapeutics
- Time in range: a best practice guide for UK diabetes healthcare professionals in the context of the COVID‐19 global pandemic
- (2020) E.G. Wilmot et al. DIABETIC MEDICINE
- An analytical approach to determine the optimal duration of continuous glucose monitoring data required to reliably estimate time in hypoglycemia
- (2020) Nunzio Camerlingo et al. Scientific Reports
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
- (2019) Tadej Battelino et al. DIABETES CARE
- Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial
- (2018) Wen Wan et al. DIABETES CARE
- Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control
- (2018) Tonya D. Riddlesworth et al. Diabetes Technology & Therapeutics
- Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study
- (2018) Monika Reddy et al. Diabetes Technology & Therapeutics
- Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
- (2018) Roy W. Beck et al. DIABETES CARE
- Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial
- (2018) Martin Tauschmann et al. LANCET
- Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes
- (2017) Thomas Haak et al. Diabetes Therapy
- Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes
- (2017) Thomas Haak et al. Diabetes Therapy
- Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial
- (2016) Jan Bolinder et al. LANCET
- Methodological issues associated with clinical trials in neuropathic pain
- (2016) Ian Gilron Expert Review of Clinical Pharmacology
- The challenges of long-term follow-up data collection in non-commercial, academically-led breast cancer clinical trials: the UK perspective
- (2014) Lucy S Kilburn et al. Trials
- Measuring the Incidence, Causes, and Repercussions of Protocol Amendments
- (2012) Kenneth A. Getz et al. DRUG INFORMATION JOURNAL
- Optimal Sampling Intervals to Assess Long-Term Glycemic Control Using Continuous Glucose Monitoring
- (2011) Dongyuan Xing et al. Diabetes Technology & Therapeutics
- The Cost-Effectiveness of Continuous Glucose Monitoring in Type 1 Diabetes
- (2010) E. S. Huang et al. DIABETES CARE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started